The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase

作者: Johan B. Nilsson , Kurt Boman , Jan-Håkan Jansson , Torbjörn Nilsson , Ulf Näslund

DOI: 10.1007/S11239-007-0086-9

关键词:

摘要: Background The fibrinolytic system and von Willebrand factor (vWF) have been shown to play a role as risk factors for myocardial infarction. We performed this prospective cohort study determine if components in the or vWF before during treatment of AMI with streptokinase (SK) could predict reperfusion, recurrent ischaemia, reinfarction mortality at one year, five years. Reperfusion ischaemia were assessed by continuous vectorcardiography. setting was Umea university hospital Skelleftea county hospital, Sweden. Results 139 patients included; successful reperfusion obtained 53%. tPA activity, PAI-activity, PAI-mass concentration analysed immediately on arrival after 4 10 h. High measured activity > 25 U/L start treatment, associated reperfusion. No significant associations between pre-treatment levels variables found. Elevated PAI-1 mass SK higher death but not worse prognosis when corrected age. Conclusion Pre-treatment PAI-1, showed no association ischaemia. prognosis.

参考文章(40)
Mats Rånby, I Birgitta Sundell, Torbjörn K Nilsson, Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thrombosis and Haemostasis. ,vol. 62, pp. 917- 922 ,(1989) , 10.1055/S-0038-1651028
Sebastian Reiz, Göran Johansson, Steen Jensen, Ulf Näslund, Göran Osterman, On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty : comparison with 12-lead electrocardiography Coronary Artery Disease. ,vol. 5, pp. 507- 514 ,(1994)
Simon G. Thompson, Joachim Kienast, Stephen D.M. Pyke, Frits Haverkate, Jürgen C.W. van de Loo, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. The New England Journal of Medicine. ,vol. 332, pp. 635- 641 ,(1995) , 10.1056/NEJM199503093321003
J Cejka, Enzyme immunoassay for factor VIII-related antigen. Clinical Chemistry. ,vol. 28, pp. 1356- 1358 ,(1982) , 10.1093/CLINCHEM/28.6.1356
E. Rapaport, Chapter 4: Calculation of Valve Areas European Heart Journal. ,vol. 6, pp. 21- 23 ,(1985) , 10.1093/EURHEARTJ/6.SUPPL_C.21
Gabriel I. Barbash, Hanoch Hod, Arie Roth, Hilton I. Miller, Shemuel Rath, Yedahel Har Zahav, Michaela Modan, Ariela Zivelin, Shlomo Laniado, Uri Seligsohn, Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. American Journal of Cardiology. ,vol. 64, pp. 1231- 1235 ,(1989) , 10.1016/0002-9149(89)90559-6
Anna M. Thögersen, Jan-Håkan Jansson, Kurt Boman, Torbjörn K. Nilsson, Lars Weinehall, Fritz Huhtasaari, Göran Hallmans, High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation. ,vol. 98, pp. 2241- 2247 ,(1998) , 10.1161/01.CIR.98.21.2241
Per Johanson, Karl Swedberg, Mikael Dellborg, ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality. Annals of Noninvasive Electrocardiology. ,vol. 6, pp. 198- 202 ,(2001) , 10.1111/J.1542-474X.2001.TB00108.X